Policy and Practice Reviews
Accepted on 19 Sep 2025
Early Access Disparities in Innovative Therapies Across the US, EU, China and Japan
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1642882
- 308 views